Chester County News and Community Website
WILMINGTON, DE — Incyte (Nasdaq: INCY) reported strong early-stage clinical results for an experimental precision antibody that sharply reduced disease markers in patients with essential thrombocythemia, bolstering hopes for a …
Incyte’s Precision Antibody Delivers Striking Results in Rare Blood Cancer Read More
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported new late-stage clinical data showing its experimental epilepsy drug EPX-100 delivered sharp and sustained seizure reductions in patients with …
Harmony’s Epilepsy Drug Cuts Seizures in Half in Key Late-Stage Study Read More
CONSHOHOCKEN, PA — Suvoda said its interactive response technology software has been named a Leader in Everest Group’s PEAK Matrix assessment for randomization and trial supply management, a recognition that …
Suvoda Named RTSM Technology Leader as Complex Trials Drive Demand Read More
MALVERN, PA — YPrime has earned two top distinctions in the 2025 Clinical Trials Arena Excellence Awards, gaining recognition for both artificial intelligence innovation and environmental leadership as pressure mounts …
YPrime Wins Dual Honors for AI Breakthroughs and Greener Clinical Trials Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) recently reported encouraging data from its pivotal bioequivalence study for pitolisant gastro-resistant (GR), marking a major milestone as the company …
Harmony’s Next-Gen Narcolepsy Drug Advances With Surprising New Results Read More
BERWYN, PA — Mural Health Technologies, Inc. has expanded its support platform for clinical trial participants by adding pre-funded meal delivery services, a move the company says will help reduce …
Mural Health Adds Meal Delivery to Ease Burden on Clinical Trial Participants Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has begun dosing participants in a Phase 1 clinical study of BP1.15205, a next-generation orexin 2 receptor agonist positioned as …
Harmony Biosciences Launches Early Trial of Promising Orexin Agonist Read More
BLUE BELL, PA — inTRAvent Medical Partners LP announced new peer-reviewed data showing that its SOLOPASS® 2.0 ultrasound-guided neuronavigation platform delivers dramatically higher accuracy than traditional freehand techniques used for …
New Study Finds Ultrasound-Guided SOLOPASS 2.0 Vastly Outperforms Freehand Brain Drain Placement Read More
WILMINGTON, DE — A new study from ChristianaCare’s Gene Editing Institute shows that disabling a single gene with CRISPR technology can restore chemotherapy sensitivity in lung cancer, a development researchers …
CRISPR Breakthrough Revives Chemo Response in Resistant Lung Tumors, Study Finds Read More
NEWARK, DE — CorriXR Therapeutics announced new peer-reviewed findings showing that its CRISPR-based gene-editing approach can resensitize squamous cell lung carcinoma (LUSC) tumors to standard chemotherapy, offering a potential path …
CRISPR Breakthrough Revives Chemo Response in Lung Cancer Models, CorriXR Reports Read More